Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
HJC0197
Cat. No.:
OB0225LY-0076
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
HJC0197 is a novel small molecule that inhibits the growth and spread of tumor cells by targeting specific biological pathways.
Synonym:
1383539-73-8; 4-Cyclopentyl-2-((2,5-dimethylbenzyl)thio)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile; 4-Cyclopentyl-2-[[(2,5-dimethylphenyl)methyl]thio]-1,6-dihydro-6-oxo-5-pyrimidinecarbonitrile; 4-Cyclopentyl-2-[(2,5-dimethylphenyl)methylsulfanyl]-6-oxo-1H-pyrimidine-5-carbonitrile; 6-Cyclopentyl-2-((2,5-dimethylbenzyl)thio)-4-oxo-1,4-dihydropyrimidine-5-carbonitrile
CAS No.:
1383539-73-8
Compound CID:
136228204
Formula:
C19H21N3OS
Formula Weight:
339.45
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
HJC0197 can be used to regulate the tumor microenvironment and enhance the immune response.
Library Information
Targets:
GTPase superfamily; cAMP effector protein family
Receptors:
Epac1; Epac2; Ras
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
h9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
25 mg/mL; 73.65 mM
